This, in turn, has an impact on the integrity of the intestinal barrier and the stability of the intestinal microenvironment, and that blocking the IL-6 -STAT3 signaling pathway through CN-encapsulated probiotics could prevent colitis-related colorectal cancer. Here, IL6 is linked to colitis.